| First Author | Carvalho-Santos A | Year | 2024 |
| Journal | PLoS One | Volume | 19 |
| Issue | 5 | Pages | e0292028 |
| PubMed ID | 38691538 | Mgi Jnum | J:351080 |
| Mgi Id | MGI:7627725 | Doi | 10.1371/journal.pone.0292028 |
| Citation | Carvalho-Santos A, et al. (2024) Anti-inflammatory role of APRIL by modulating regulatory B cells in antigen-induced arthritis. PLoS One 19(5):e0292028 |
| abstractText | APRIL (A Proliferation-Inducing Ligand), a member of the TNF superfamily, was initially described for its ability to promote proliferation of tumor cells in vitro. Moreover, this cytokine has been related to the pathogenesis of different chronic inflammatory diseases, such as rheumatoid arthritis. This study aimed to evaluate the ability of APRIL in regulating B cell-mediated immune response in the antigen-induced arthritis (AIA) model in mice. AIA was induced in previously immunized APRIL-transgenic (Tg) mice and their littermates by administration of antigen (mBSA) into the knee joints. Different inflammatory cell populations in spleen and draining lymph nodes were analyzed using flow cytometry and the assay was performed in the acute and chronic phases of the disease, while cytokine levels were assessed by ELISA. In the acute AIA, APRIL-Tg mice developed a less severe condition and a smaller inflammatory infiltrate in articular tissues when compared with their littermates. We also observed that the total cellularity of draining lymph nodes was decreased in APRIL-Tg mice. Flow cytometry analysis revealed an increase of CD19+IgM+CD5+ cell population in draining lymph nodes and an increase of CD19+CD21hiCD23hi (B regulatory) cells in APRIL-Tg mice with arthritis as well as an increase of IL-10 and CXCL13 production in vitro. |
